MPTRVT

Cystic Fibrosis (CF) is an autosomal recessive disorder affecting the lungs, pancreas, intestine and liver. CF is the most common in Caucasians with an incidence rate 1:2500 newborns. CF is caused by mutation in the gene for the protein cystic fibrosis transmembrane conductance regulator (CTFR) [1,2]. Large-scale neonatal screening for CF is performed by indentification of increased levels of immunoreactive trypsinogen (IRT) in blood.

Biocard™ Rapid test for HCV antibodies is developed based on Antibody sandwich by Lateralflow immunochromatography assay for the qualitative detection of antibodies to HCV infection by using Core, NS3, NS4 and NS5 Antigens.All the accessories needed for the sampling and testing are included.Works on Serum/Plasma and Whole Blood.Results can be obtained in 20 minutes.

Labsystems Diagnostics’ Neonatal 17-OH-Progesterone FEIA test is a fluorometric enzyme immunoassay enabling the quantification of 17-hydroxyprogestrone steroid present in blood samples dried on filter paper. The test can be used for the screening of newborn for Congenital Adrenal Hyperplasia (CAH).

Biocard™ Human Chorionic Gonadotropin is a qualitative assay test kit by lateral flow method for detection of hCG antigen in Human urine with great sensitivity and specificity.All the accessories needed for the sampling and testing are included.Works on Human urineResults can be obtained in 20 minutes

Reliable Newborn Screening devices provided by Labsystems Diagnostics.

Biocard™ Malaria Pf/PAN antigen diagnostic kit is a pLDH Antigen capture test kit for differential detection of Malaria P.falciparum and PAN Malarial species by pLDH antigen capture method.All the accessories needed for the sampling and testing are included.Works on Human Whole blood.Results can be obtained in 20 minutes.